ALK and cancer: Given the peculiar macrophage signature recently uncovered in patients diagnosed with luminal subtypes (66), future efforts will also aim to define the requirement for ALK1 signaling in bone tropism of cancer cells as well as the conceivable interplay between the hematopoietic and metastatic niches during tumor evolution.